Zimmer Biomet (ZBH) PT Lowered to $137 at BMO Capital; 'Making Very Early Progress, Resetting the Bar'
Tweet
Share
E-mailGet Alerts ZBH Hot Sheet
Price: $94.22 -3.93%
Rating Summary:
18 Buy, 26 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 26 | Down: 25 | New: 65
Rating Summary:
18 Buy, 26 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 26 | Down: 25 | New: 65
Join SI Premium – FREE
BMO Capital lowered its price target on Zimmer Biomet (NYSE: ZBH) to $137.00 (from $144.00) while maintaining a Outperform rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Canaan Inc. (CAN) PT Lowered to $2 at BTIG
- BMO Capital Starts Urban Outfitters, Inc. (URBN) at Market Perform
- BMO Capital Starts Nike (NKE) at Underperform
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
BMO CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
